Johnson Financial Group Inc (Wisconsin)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Sell
534
-43
-7% -$24.2K 0.01% 281
2026
Q1
$342K Hold
577
– – 0.01% 259
2025
Q4
$281K Sell
577
-138
-19% -$64.3K 0.01% 287
2025
Q3
$300K Sell
715
-4
-0.6% -$1.34K 0.01% 302
2025
Q2
$207K Buy
719
+2
+0.3% +$598 0.01% 299
2025
Q1
$221K Sell
717
-34
-5% -$11.7K 0.01% 332
2024
Q4
$264K Sell
751
-194
-21% -$71.3K 0.01% 269
2024
Q3
$339K Sell
945
-361
-28% -$122K 0.02% 283
2024
Q2
$416K Buy
+1,306
New +$346K 0.02% 231
2015
Q4
– Sell
-24
Closed -$3K – 814
2015
Q3
$3K Hold
24
– – ﹤0.01% 742
2015
Q2
$4K Hold
24
– – ﹤0.01% 771
2015
Q1
$4K Hold
24
– – ﹤0.01% 746
2014
Q4
$3K Hold
24
– – ﹤0.01% 730
2014
Q3
$3K Hold
24
– – ﹤0.01% 691
2014
Q2
$2K Hold
24
– – ﹤0.01% 677
2014
Q1
$2K Hold
24
– – ﹤0.01% 688
2013
Q4
$3K Hold
24
– – ﹤0.01% 654
2013
Q3
$2K Hold
24
– – ﹤0.01% 655
2013
Q2
$2K Buy
+24
New +$1.55K ﹤0.01% 674

Other funds holding UTHR

Johnson Financial Group Inc (Wisconsin)'s UTHR Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) reduced its United Therapeutics (UTHR) stake by 7.5% in Q2 2026, selling an estimated $24.2K and leaving 534 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #281.

Johnson Financial Group Inc (Wisconsin) first reported a position in UTHR in Q2 2013 and has held it in 19 quarters since. The position peaked at $416K in Q2 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 534 shares of United Therapeutics worth $289K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) sold 43 United Therapeutics shares in Q2 2026, an estimated $24.2K.
  • United Therapeutics made up 0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #281 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in United Therapeutics in Q2 2013 and has held it in 19 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s United Therapeutics position peaked at $416K in Q2 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.